Embedded Files
This site is in archive mode. Please confirm all information with program before seeking services.
There are various studies happening to research Mpox (formerly known as the monkeypox virus, MPV, and MPX) in humans. Below is a listing of the verified studies and how New Yorkers can enroll in them.
Help Us Spread the Word
We need your help to spread the word to New Yorkers that may be in need of information about Monkeypox Testing, Treatment, Prevention, and Vaccines. Please share our social media posts on your streams to help us get the word out!
STOMP A5418 Clinical Trials
STOMP A5418 Clinical Trials
Phase 3 clinical trial evaluating the antiviral tecovirimat (TPOXX).
Program Summary
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring a Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, for the treatment of human Mpox infection.
More Information
Program Details
Compensation available for trial participants
Must have an active or suspected Mpox infection
Enrollment Information
Contact the trial location directly to schedule an intake appointment. Each site may have slightly different criteria for enrollment.
Requirements
Photo Identification
Non-Photo Identification
Restrictions
None
Weill Cornell Medical Center
Weill Cornell Medical Center
212.746.4177 | email
ADA Accessibility
Yes, fully accessible
Listing ID: 3419775096
Site Notes
Locations in Chelsea and Upper East Side
Appointments only, walk-ins not available.
Ages 18 and older only
Mount Sinai Hospital
Mount Sinai Hospital
Clinical and Translation Research Center
Samuels Clinic
212.824.7714 | email
ADA Accessibility
Yes, fully accessible
Listing ID: 3437045034
Site Notes
Locations in Upper East Side and Upper West Side
Appointments only, walk-ins not available.
Ages 18 and older only
...
NYC OSMI
NYC OSMI
New York City Observational Study of Mpox Immunity
Program Summary
The goal of this study is to assess the immune response, tolerance, and safety of the low-dose intradermal (forearm) mpox vaccine in people who are HIV+ compared to people who are HIV-, and compared to the standard-dose subcutaneous (upper arm) vaccine. The resulting data will fill knowledge gaps, inform public health practices, and address community concerns about the absence of data for low-dose intradermal mpox vaccinations in people living with HIV.
More Information
NYU Vaccine Center
NYU Langone Health Clinical Research Studies
Program Details
Compensation available for trial participants. Appoximately $85 per visit.
Enrollment Information
Complete the online inquiry form to enroll into the study.
Call to schedule.
Email to schedule
Study Type
Observational
In-person visits only.
Requirements
18 years of age and older
Those who received the Mpox vaccine; and/or planning to get the MPox vaccine.
Restrictions
Certain Medical conditions are excluded. Please complete the pre-screening to find out if you're eligible.
Site Notes
The study site is in Kipps Bay/Midtown East, Manhattan only.
...
Spread the Word
Spread the Word
Help Us Spread the Word
Help Us Spread the Word
We need your help to spread the word to New Yorkers that may be in need of information about Mpox Testing, Treatment, Prevention, and Vaccines. Please share our social media posts on your streams to help us get the word out!
Page ID: 3344034710
Report abuse